+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Yttrium-90"

Radiopharmaceuticals Market By End User, By Radioisotope, By Application, By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Thumbnail Image

Radiopharmaceuticals Market By End User, By Radioisotope, By Application, By Type: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • April 2024
  • 500 Pages
  • Global
From
Loading Indicator

Yttrium-90 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the treatment of cancer, as well as other diseases, and is produced in nuclear reactors. Yttrium-90 is used in a variety of medical applications, including targeted radiotherapy, radioembolization, and radioimmunotherapy. It is also used in the diagnosis of certain diseases, such as liver cancer. Yttrium-90 is produced in a variety of forms, including microspheres, nanospheres, and liquid formulations. It is also available in a variety of formulations, including capsules, tablets, and injectables. The Yttrium-90 market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Nordion, Eckert & Ziegler, IBA Molecular, and Advanced Accelerator Applications. Show Less Read more